# Setmelanotide in Bardet-Biedl syndrome: quality of life

Source: https://pepvault.app/research/setmelanotide-forsythe-2023

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Setmelanotide](https://pepvault.app/research#setmelanotide)

Clinical trial · people

# Setmelanotide: quality of life rose after 52 weeks in Bardet-Biedl

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

For people with Bardet-Biedl syndrome, this trial adds that a year on setmelanotide came with meaningful gains in self-reported quality of life, and in adults those gains moved with weight change.

- **Kind:** Clinical trial
- **Studied in:** People
- **Published:** 2023
- **Journal:** Orphanet J Rare Dis

## What they tested

The team asked whether health-related quality of life changed in children and adults with Bardet-Biedl syndrome, a rare genetic disease tied to constant hunger and severe early obesity, after 1 year of setmelanotide.

## How the study was done

In a phase 3 trial, people with Bardet-Biedl syndrome and obesity received setmelanotide for 52 weeks. This analysis described changes in 9 patients under 18 and 11 adults who filled in quality of life questionnaires at the start of active treatment and at 52 weeks, without a comparison group.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In those under 18, the PedsQL score (a pediatric quality of life questionnaire, where a 4.4-point change counts as meaningful) rose by a mean of +11.2. All 4 young patients whose scores showed impairment at the start improved by a clinically meaningful amount. In adults, the IWQOL-Lite score (a questionnaire on how weight affects daily life, where a 7.7 to 12-point change counts as meaningful) rose by a mean of +12.0, and 62.5% of the 8 adults with impaired scores at the start improved meaningfully. Among adults, the IWQOL-Lite score was significantly linked to how much their weight shifted in percent terms (P = 0.0037) and to the shift in BMI, a weight-for-height measure (P = 0.0098).

## What it doesn’t show

This was a small group, and the results are descriptive with no placebo comparison, so they cannot show how much of the change came from the drug itself. Scores were self-reported or caregiver-reported, and only patients with data at both time points were included.

## The paper

Forsythe et al. Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results. Orphanet J Rare Dis. 2023.

- [PubMed (PMID 36647077)](https://pubmed.ncbi.nlm.nih.gov/36647077/)
- [The paper (DOI 10.1186/s13023-022-02602-4)](https://doi.org/10.1186/s13023-022-02602-4)
- [ClinicalTrials.gov (NCT03746522)](https://clinicaltrials.gov/study/NCT03746522)

## The compound

- [Setmelanotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Setmelanotide

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026) Meta-analysis · people · 2026
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026) Randomized trial · people · 2026
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856) Clinical trial · people · 2026
- [Setmelanotide: mean BMI fell 18% at 52 weeks in ages 2-5 (VENTURE)](https://pepvault.app/research/setmelanotide-venture-2025) Clinical trial · people · 2025
- [Setmelanotide: 15% mean BMI drop at 16 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-roth-2024) Clinical trial · people · 2024
- [Setmelanotide: 80% (POMC) and 45% (LEPR) lost at least 10% weight](https://pepvault.app/research/setmelanotide-clement-2020) Clinical trial · people · 2020
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

## The library

- [Setmelanotide](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
